Cidara Therapeutics's market cap is currently $2.76B. The company's EPS TTM is $-1.65; its P/E ratio is -9.79; Cidara Therapeutics is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-1.34. See an overview of income statement, balance sheet, and cash flow financials.
